title: A PET for All Seasons:18F-Fluorodeoxyglucose to Characterize Inflammation and Malignancy in Retroperitoneal Fibrosis?
authors.affiliation: Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Department of Nuclear Medicine, Ludwig-Maximilians University Munich, Munich, Germany. Electronic address: wfendler@mednet.ucla.edu.
authors.forename: Wolfgang P
authors.initials: WP
authors.lastname: Fendler
authors.affiliation: Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
authors.forename: Matthias
authors.initials: M
authors.lastname: Eiber
authors.affiliation: Department of Urology, Ludwig-Maximilians University Munich, Munich, Germany.
authors.forename: Christian G
authors.initials: CG
authors.lastname: Stief
authors.affiliation: Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Klinik für Nuklearmedizin, Universitätsklinikum Essen, Essen, Germany.
authors.forename: Ken
authors.initials: K
authors.lastname: Herrmann
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D007249:Inflammation; D009369:Neoplasms; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D012185:Retroperitoneal Fibrosis; D014057:Tomography, X-Ray Computed
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18